Logo image of BOXD

BOXED INC (BOXD) Stock Fundamental Analysis

NYSE:BOXD - New York Stock Exchange, Inc. - US1031741085 - Common Stock - Currency: USD

0.1898  -0.03 (-15.27%)

Premarket: 0.1971 +0.01 (+3.85%)

Fundamental Rating

1

Overall BOXD gets a fundamental rating of 1 out of 10. We evaluated BOXD against 41 industry peers in the Consumer Staples Distribution & Retail industry. Both the profitability and financial health of BOXD have multiple concerns. BOXD does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BOXD had negative earnings in the past year.
BOXD Yearly Net Income VS EBIT VS OCF VS FCFBOXD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -20M -40M -60M

1.2 Ratios

The profitability ratios for BOXD are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BOXD Yearly ROA, ROE, ROICBOXD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 1K 2K 3K 4K

1.3 Margins

The Gross Margin of BOXD (17.98%) is worse than 65.00% of its industry peers.
BOXD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 17.98%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BOXD Yearly Profit, Operating, Gross MarginsBOXD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 0 10 -10 -20 -30

More info and screens

2

2. Health

2.1 Basic Checks

BOXD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BOXD remains at a similar level compared to 1 year ago.
The debt/assets ratio for BOXD is higher compared to a year ago.
BOXD Yearly Shares OutstandingBOXD Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 20M 40M 60M
BOXD Yearly Total Debt VS Total AssetsBOXD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 50M 100M 150M 200M

2.2 Solvency

BOXD has an Altman-Z score of -5.29. This is a bad value and indicates that BOXD is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BOXD (-5.29) is worse than 90.00% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.29
ROIC/WACCN/A
WACC2.96%
BOXD Yearly LT Debt VS Equity VS FCFBOXD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 50M -50M 100M

2.3 Liquidity

BOXD has a Current Ratio of 1.34. This is a normal value and indicates that BOXD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.34, BOXD is in line with its industry, outperforming 55.00% of the companies in the same industry.
A Quick Ratio of 1.13 indicates that BOXD should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.13, BOXD is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.34
Quick Ratio 1.13
BOXD Yearly Current Assets VS Current LiabilitesBOXD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for BOXD have decreased strongly by -101.01% in the last year.
Looking at the last year, BOXD shows a decrease in Revenue. The Revenue has decreased by -5.29% in the last year.
EPS 1Y (TTM)-101.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-296.73%
Revenue 1Y (TTM)-5.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

BOXD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.34% yearly.
Based on estimates for the next years, BOXD will show a quite strong growth in Revenue. The Revenue will grow by 18.22% on average per year.
EPS Next Y2.35%
EPS Next 2Y21.36%
EPS Next 3Y19.14%
EPS Next 5Y15.34%
Revenue Next Year-0.51%
Revenue Next 2Y8.21%
Revenue Next 3Y12.39%
Revenue Next 5Y18.22%

3.3 Evolution

BOXD Yearly Revenue VS EstimatesBOXD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
BOXD Yearly EPS VS EstimatesBOXD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5 -1 -1.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

BOXD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BOXD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BOXD Price Earnings VS Forward Price EarningsBOXD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BOXD Per share dataBOXD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2

4.3 Compensation for Growth

A more expensive valuation may be justified as BOXD's earnings are expected to grow with 19.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.36%
EPS Next 3Y19.14%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BOXD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOXED INC

NYSE:BOXD (3/31/2023, 8:05:34 PM)

Premarket: 0.1971 +0.01 (+3.85%)

0.1898

-0.03 (-15.27%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)03-14 2023-03-14
Earnings (Next)05-08 2023-05-08
Inst Owners0.01%
Inst Owner Change0%
Ins Owners11.36%
Ins Owner Change0%
Market Cap14.01M
Analysts82.22
Price Target2.7 (1322.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-43.3%
Min EPS beat(2)-51.08%
Max EPS beat(2)-35.52%
EPS beat(4)0
Avg EPS beat(4)-84.48%
Min EPS beat(4)-221.23%
Max EPS beat(4)-30.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.31%
Min Revenue beat(2)-14.48%
Max Revenue beat(2)3.87%
Revenue beat(4)1
Avg Revenue beat(4)-3.84%
Min Revenue beat(4)-14.48%
Max Revenue beat(4)3.87%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)18.66%
PT rev (3m)18.66%
EPS NQ rev (1m)-21.46%
EPS NQ rev (3m)-21.46%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.39%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.03%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.15
EYN/A
EPS(NY)-0.92
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.4
BVpS-0.96
TBVpS-1.06
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 17.98%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover1.49
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.34
Quick Ratio 1.13
Altman-Z -5.29
F-Score3
WACC2.96%
ROIC/WACCN/A
Cap/Depr(3y)48.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-101.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-296.73%
EPS Next Y2.35%
EPS Next 2Y21.36%
EPS Next 3Y19.14%
EPS Next 5Y15.34%
Revenue 1Y (TTM)-5.29%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-0.51%
Revenue Next 2Y8.21%
Revenue Next 3Y12.39%
Revenue Next 5Y18.22%
EBIT growth 1Y-70.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-51.37%
EBIT Next 3Y18.23%
EBIT Next 5Y20.57%
FCF growth 1Y-112.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.89%
OCF growth 3YN/A
OCF growth 5YN/A